Douglas R. Silveira

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

ΔNp73 isoform defines a TP53-mutant-like poor-risk subgroup of acute myeloid leukemia.

ΔNp73 isoform defines a TP53-mutant-like poor-risk subgroup of acute myeloid leukemia.

Journal: Cell reports. Medicine

Published: March 04, 2025

High mtDNA content identifies oxidative phosphorylation-driven acute myeloid leukemias and represents a therapeutic vulnerability.

High mtDNA content identifies oxidative phosphorylation-driven acute myeloid leukemias and represents a therapeutic vulnerability.

Journal: Signal transduction and targeted therapy

Published: September 07, 2024

Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia.

Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia.

Journal: British journal of haematology

Published: August 15, 2022

Co-codamol okay.

Co-codamol okay.

Journal: British dental journal

Published: October 10, 2020

Reduced SLIT2 is Associated with Increased Cell Proliferation and Arsenic Trioxide Resistance in Acute Promyelocytic Leukemia.

Reduced SLIT2 is Associated with Increased Cell Proliferation and Arsenic Trioxide Resistance in Acute Promyelocytic Leukemia.

Journal: Cancers

Published: September 29, 2020

Co-occurrence of DNMT3A, NPM1, FLT3 mutations identifies a subset of acute myeloid leukemia with adverse prognosis.

Co-occurrence of DNMT3A, NPM1, FLT3 mutations identifies a subset of acute myeloid leukemia with adverse prognosis.

Journal: Blood

Published: January 25, 2020

Association between ANXA2*5681 polymorphism (rs7170178) and osteonecrosis in haemoglobin SS-genotyped patients.

Association between ANXA2*5681 polymorphism (rs7170178) and osteonecrosis in haemoglobin SS-genotyped patients.

Journal: British journal of haematology

Published: November 12, 2019

Combining gene mutation with gene expression analysis improves outcome prediction in acute promyelocytic leukemia.

Combining gene mutation with gene expression analysis improves outcome prediction in acute promyelocytic leukemia.

Journal: Blood

Published: February 19, 2019

Showing 1-8 of 8

Last Updated: 09/26/2026